- Home
- FLXS vs PROK Comparison
FLXS vs PROK Comparison
Compare FLXS & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLXS
- PROK
- Stock Information
- Founded
- FLXS 2001
- PROK 2015
- Country
- FLXS United States
- PROK United States
- Employees
- FLXS N/A
- PROK N/A
- Industry
- FLXS Home Furnishings
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLXS Consumer Discretionary
- PROK Health Care
- Exchange
- FLXS Nasdaq
- PROK Nasdaq
- Market Cap
- FLXS 250.5M
- PROK 417.1M
- IPO Year
- FLXS N/A
- PROK N/A
- Fundamental
- Price
- FLXS $34.59
- PROK $2.80
- Analyst Decision
- FLXS
- PROK Strong Buy
- Analyst Count
- FLXS 0
- PROK 4
- Target Price
- FLXS N/A
- PROK $6.25
- AVG Volume (30 Days)
- FLXS 48.6K
- PROK 2.1M
- Earning Date
- FLXS 10-20-2025
- PROK 11-12-2025
- Dividend Yield
- FLXS 2.30%
- PROK N/A
- EPS Growth
- FLXS 64.53
- PROK N/A
- EPS
- FLXS 4.11
- PROK N/A
- Revenue
- FLXS $447,505,000.00
- PROK $527,000.00
- Revenue This Year
- FLXS $3.93
- PROK $471.74
- Revenue Next Year
- FLXS $4.20
- PROK N/A
- P/E Ratio
- FLXS $8.46
- PROK N/A
- Revenue Growth
- FLXS 6.00
- PROK N/A
- 52 Week Low
- FLXS $29.38
- PROK $0.46
- 52 Week High
- FLXS $65.87
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- FLXS 31.72
- PROK 43.68
- Support Level
- FLXS $34.00
- PROK $2.90
- Resistance Level
- FLXS $36.63
- PROK $3.27
- Average True Range (ATR)
- FLXS 2.01
- PROK 0.22
- MACD
- FLXS -0.20
- PROK -0.06
- Stochastic Oscillator
- FLXS 5.32
- PROK 11.92
About FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.